These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 12631632)
1. Dr. Gary J. Becker Young Investigator Award: intraarterial adenovirus for metastatic gastrointestinal cancer: activity, radiographic response, and survival. Sze DY; Freeman SM; Slonim SM; Samuels SL; Andrews JC; Hicks M; Ahrar K; Gupta S; Reid TR J Vasc Interv Radiol; 2003 Mar; 14(3):279-90. PubMed ID: 12631632 [TBL] [Abstract][Full Text] [Related]
2. Intra-arterial administration of a replication-selective adenovirus (dl1520) in patients with colorectal carcinoma metastatic to the liver: a phase I trial. Reid T; Galanis E; Abbruzzese J; Sze D; Andrews J; Romel L; Hatfield M; Rubin J; Kirn D Gene Ther; 2001 Nov; 8(21):1618-26. PubMed ID: 11895000 [TBL] [Abstract][Full Text] [Related]
3. Effects of Onyx-015 among metastatic colorectal cancer patients that have failed prior treatment with 5-FU/leucovorin. Reid TR; Freeman S; Post L; McCormick F; Sze DY Cancer Gene Ther; 2005 Aug; 12(8):673-81. PubMed ID: 15803147 [TBL] [Abstract][Full Text] [Related]
4. Hepatic arterial infusion of a replication-selective oncolytic adenovirus (dl1520): phase II viral, immunologic, and clinical endpoints. Reid T; Galanis E; Abbruzzese J; Sze D; Wein LM; Andrews J; Randlev B; Heise C; Uprichard M; Hatfield M; Rome L; Rubin J; Kirn D Cancer Res; 2002 Nov; 62(21):6070-9. PubMed ID: 12414631 [TBL] [Abstract][Full Text] [Related]
5. Pilot trial of intravenous infusion of a replication-selective adenovirus (ONYX-015) in combination with chemotherapy or IL-2 treatment in refractory cancer patients. Nemunaitis J; Cunningham C; Tong A; Post L; Netto G; Paulson AS; Rich D; Blackburn A; Sands B; Gibson B; Randlev B; Freeman S Cancer Gene Ther; 2003 May; 10(5):341-52. PubMed ID: 12719704 [TBL] [Abstract][Full Text] [Related]
6. Hepatic transcatheter arterial chemoembolization alternating with systemic protracted continuous infusion 5-fluorouracil for gastrointestinal malignancies metastatic to liver: a phase II trial of the Puget Sound Oncology Consortium (PSOC 1104). Bavisotto LM; Patel NH; Althaus SJ; Coldwell DM; Nghiem HV; Thompson T; Storer B; Thomas CR Clin Cancer Res; 1999 Jan; 5(1):95-109. PubMed ID: 9918207 [TBL] [Abstract][Full Text] [Related]
7. Hepatic arterial oxaliplatin infusion plus intravenous chemotherapy in colorectal cancer with inoperable hepatic metastases: a trial of the gastrointestinal group of the Federation Nationale des Centres de Lutte Contre le Cancer. Ducreux M; Ychou M; Laplanche A; Gamelin E; Lasser P; Husseini F; Quenet F; Viret F; Jacob JH; Boige V; Elias D; Delperro JR; Luboinski M; J Clin Oncol; 2005 Aug; 23(22):4881-7. PubMed ID: 16009952 [TBL] [Abstract][Full Text] [Related]
8. Sequential intrahepatic fluorodeoxyuridine and systemic fluorouracil plus leucovorin for the treatment of metastatic colorectal cancer confined to the liver. O'Connell MJ; Nagorney DM; Bernath AM; Schroeder G; Fitzgibbons RJ; Mailliard JA; Burch P; Bolton JS; Colon-Otero G; Krook JE J Clin Oncol; 1998 Jul; 16(7):2528-33. PubMed ID: 9667274 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of a Phase I/II Trial of Hepatic Arterial Infusion of Oxaliplatin Combined with Intravenous 5-Fluorouracil and l-Leucovorin in Patients with Unresectable Liver Metastases from Colorectal Cancer After Systemic Chemotherapy Failure. Sato Y; Inaba Y; Ura T; Nishiofuku H; Yamaura H; Kato M; Takahari D; Tanaka T; Muro K J Gastrointest Cancer; 2018 Jun; 49(2):132-137. PubMed ID: 28058527 [TBL] [Abstract][Full Text] [Related]
10. Randomized, multicenter trial of fluorouracil plus leucovorin administered either via hepatic arterial or intravenous infusion versus fluorodeoxyuridine administered via hepatic arterial infusion in patients with nonresectable liver metastases from colorectal carcinoma. Lorenz M; Müller HH J Clin Oncol; 2000 Jan; 18(2):243-54. PubMed ID: 10637236 [TBL] [Abstract][Full Text] [Related]
11. A pilot study of hepatic artery floxuridine combined with systemic 5-fluorouracil and leucovorin. A potential adjuvant program after resection of colorectal hepatic metastases. Kemeny N; Conti JA; Sigurdson E; Cohen A; Seiter K; Lincer R; Niedzwiecki D; Botet J; Chapman D; Costa P Cancer; 1993 Mar; 71(6):1964-71. PubMed ID: 8443746 [TBL] [Abstract][Full Text] [Related]
12. Phase I clinical and pharmacokinetic study of leucovorin and infusional hepatic arterial fluorouracil. Kerr DJ; Ledermann JA; McArdle CS; Buckels J; Neoptolemos J; Seymour M; Doughty J; Budden J; Taylor I J Clin Oncol; 1995 Dec; 13(12):2968-72. PubMed ID: 8523062 [TBL] [Abstract][Full Text] [Related]
13. [Intra-arterial 5-FU/intra-venous MTX therapy for metastatic liver lesions]. Adachi S; Fukao K; Chikamori F; Yuzawa K; Shibuya S; Nozue M; Otsuka M; Ishikawa A; Todoroki T Gan To Kagaku Ryoho; 1995 Sep; 22(11):1457-9. PubMed ID: 7574731 [TBL] [Abstract][Full Text] [Related]
14. Phase II trial of hepatic arterial infusion of fluorouracil and recombinant human interferon alfa-2b for liver metastases of colorectal cancer refractory to systemic fluorouracil and leucovorin. Patt YZ; Hoque A; Lozano R; Pozdur R; Chase J; Carrasco H; Chuang V; Delpassand ES; Ellis L; Curley S; Roh M; Jones DV J Clin Oncol; 1997 Apr; 15(4):1432-8. PubMed ID: 9193336 [TBL] [Abstract][Full Text] [Related]
15. Folfox4 regimen administered through combined hepatic arterial and systemic infusion for treatment of colorectal cancer with unresectable liver metastases. Guan M; Chen SC; Ying HY; Zhao L; Li XY; Zhou JF; Shao YJ; Yang XD; Lin Y; Ning XH; Bai CM Chin Med J (Engl); 2012 Oct; 125(20):3640-5. PubMed ID: 23075717 [TBL] [Abstract][Full Text] [Related]
16. Phase II study of weekly 24-hour intra-arterial high-dose infusion of 5-fluorouracil and folinic acid for liver metastases from colorectal carcinomas. Lorenz M; Mueller HH; Mattes E; Gassel HJ; Junginger T; Saeger HD; Schramm H; Staib-Sebler E; Vetter G; Heinrich S; Köhne CH; Ann Oncol; 2001 Mar; 12(3):321-5. PubMed ID: 11332142 [TBL] [Abstract][Full Text] [Related]
17. Phase I trial of systemic oxaliplatin combination chemotherapy with hepatic arterial infusion in patients with unresectable liver metastases from colorectal cancer. Kemeny N; Jarnagin W; Paty P; Gönen M; Schwartz L; Morse M; Leonard G; D'Angelica M; DeMatteo R; Blumgart L; Fong Y J Clin Oncol; 2005 Aug; 23(22):4888-96. PubMed ID: 16009951 [TBL] [Abstract][Full Text] [Related]
18. Repetitive chemoembolization with melphalan plus intra-arterial immuno-chemotherapy within 5-fluorouracil and granulocyte-macrophage colony-stimulating factor (GM-CSF) as effective first- and second-line treatment of disseminated colorectal liver metastases. Müller H; Nakchbandi V; Chatzisavvidis I; von Voigt C Hepatogastroenterology; 2003; 50(54):1919-26. PubMed ID: 14696433 [TBL] [Abstract][Full Text] [Related]
19. [A case of metastatic colon carcinoma in which a continuous intrahepatic artery-infusion of 5-FU leucovorin and cisplatin, and systemic chemotherapy with CPT-11 was very effective]. Ishikawa T; Nakamura M; Ohkuma K; Hisano C; Nakano S; Maruyama T; Kaji Y; Niho Y; Masumoto N Gan To Kagaku Ryoho; 2000 Aug; 27(9):1443-7. PubMed ID: 10969604 [TBL] [Abstract][Full Text] [Related]
20. [Continuous hepatic arterial infusion of fluorouracil with leucovorin for liver metastases from colorectal cancer]. Yamamura T; Matsuzaki H; Hashizume R; Arifuku T; Adachi Y; Nagaoka S; Kimura M; Akaishi O; Tsukikawa S Gan To Kagaku Ryoho; 1997 Sep; 24(12):1691-4. PubMed ID: 9382508 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]